Governance Avacta Group Plc

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:28 13/03/2026 pm IST			5-day change	1st Jan Change
71.00 ^GBX	-1.39%		+5.19%	+22.41%

24/02	Avacta hails new data supporting proprietary preCision platform	AN
24/02	Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis	MT

Executive Committee: Avacta Group Plc

Manager

Positions heldSince

Christina Coughlin

56 year

Chief Executive Officer

01/04/2024

David Liebowitz

Chief Tech/Sci/R&D Officer

01/07/2025

Francis X. Wilson

Chief Tech/Sci/R&D Officer

09/02/2026

Brian Hahn

51 year

Director of Finance/CFO	22/01/2025
Corporate Secretary	22/01/2025

Composition of the Board of Directors: Avacta Group Plc

Director

CommitteesSince

Shaun Chilton

59 year

Audit Committee	24/06/2024
Compensation Committee	24/06/2024

Paul Fry

60 year

Compensation Committee	03/02/2020
Audit Committee Chair	03/02/2020

Mark Goldberg

71 year

Compensation Committee Chair

01/05/2025

Christina Coughlin

56 year

Director/Board Member

18/03/2022

David Bryant

59 year

Director/Board Member	28/05/2025
Independent Dir/Board Member	28/05/2025

Richard Hughes

58 year

Director/Board Member	28/05/2025
Independent Dir/Board Member	28/05/2025

Latest Appointments: Avacta Group Plc

09/02	Avacta appoints new chief scientific officer, plans clinical trials	AN
09/02	Avacta Therapeutics Names Chemistry Vice President as Chief Scientific Officer	MT
09/02	Avacta Therapeutics Announces Executive Changes	CI
22/25/22	CORRECT (Sep 01): hVIVO appoints Avacta Chair Shaun Chilton to board	AN
01/25/01	HVIVO appoints Avacta Chair Shaun Chilton to lead board	AN
02/25/02	EXECUTIVE CHANGES: Avacta names CMO, Mission Group appoints CEO	AN
01/25/01	Avacta Group Names Chief Medical Officer	MT

More news

Former Officers and Directors: Avacta Group Plc

Insider

Positions held

SinceUntil

Darlene Deptula-Hicks

Director/Board Member

26/06/2024

01/07/2025

Trevor Nicholls

Director/Board Member	11/06/2018	30/04/2025
Chairman	02/08/2013	11/06/2018
Independent Dir/Board Member	02/08/2013	30/04/2025

Tony Gardiner

Director/Board Member	04/01/2016	13/01/2025
Director of Finance/CFO	04/01/2016	13/01/2025

Eliot Forster

Chairman

11/06/2018

20/06/2024

Fiona McLaughlin

Chief Tech/Sci/R&D Officer	-	01/06/2024
Corporate Officer/Principal	02/09/2021	-

Alastair Smith

Director/Board Member	01/01/2005	01/05/2024
Chief Executive Officer	01/01/2005	01/05/2024
Founder	01/01/2004	01/05/2024

Simon Bennett

Corporate Officer/Principal

19/12/2023

Neil Bell

Corporate Officer/Principal

01/07/2020

01/12/2023

Joanne Soundy

Sales & Marketing

01/11/2020

01/08/2022

Rob Ford

Corporate Officer/Principal

01/08/2020

01/04/2022

Chris Miller

Corporate Officer/Principal

01/12/2017

01/04/2022

Fran Mullen

Corporate Officer/Principal

01/08/2017

01/11/2021

Michael Owen

Director/Board Member	17/09/2015	24/03/2021
Independent Dir/Board Member	-	24/03/2021

Samuel Cameron Williams

Director/Board Member

28/01/2019

04/11/2019

Alan Aubrey

Director/Board Member

13/07/2006

21/01/2019

Jose Saro

Chief Tech/Sci/R&D Officer

12/12/2018

Michael Albin

Director/Board Member

05/02/2014

30/03/2018

Philippe Cotrel

Corporate Officer/Principal

25/01/2016

Timothy Sykes

Director/Board Member	24/12/2010	10/12/2015
Director of Finance/CFO	01/04/2006	10/12/2015
Corporate Secretary	08/02/2010	10/12/2015

Amrik Basran

Chief Tech/Sci/R&D Officer

01/03/2015

Gwynfor Humphreys

Director/Board Member	13/07/2006	23/01/2015
Chairman	24/12/2010	24/01/2014

Anthony William Robards

Director/Board Member

08/02/2010

24/01/2014

Matt Johnson

Chief Tech/Sci/R&D Officer	16/09/2013	-
Corporate Officer/Principal	01/05/2014	-

Richard Craig Alan Slater

Director/Board Member	01/06/2012	20/01/2017
Chief Operating Officer	01/06/2012	-
Director of Finance/CFO	07/07/2015	04/01/2016

Barry Porter

Director/Board Member

08/02/2010

17/03/2011

Daron R. Lee

Director/Board Member

07/08/2006

Russell Winston Hodgetts

Chief Operating Officer

01/10/2005

Kurt Baldwin

Director/Board Member	01/01/2004	24/12/2010
Chief Tech/Sci/R&D Officer	24/12/2010	-
Founder	01/01/2004	-

Simon Webster

Chief Tech/Sci/R&D Officer	08/02/2010	-
Founder	01/01/2004	-

Paul Ko Ferrigno

Chief Tech/Sci/R&D Officer

Ged Holmes

Corporate Officer/Principal

Alexander Stevenson

President

Age distribution of managers

Parity Men Women

Male	10
Female	0

Of which Executive Committee

Male	4
Female	0

Of which Directors

Male	6
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics. It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Employees

151

Sector

Biotechnology & Medical Research

More about the company